Search results

Jump to navigation Jump to search
  • ...n agonist of [[Biogenic amine receptor|5-hydroxytryptamine<sub>4</sub>]] [[cell surface receptor]]s that may treat severe chronic constipation.<ref name="pmid18509121">{{ci Methylnaltrexone is an antagonist of [[opioid receptor|opioid mu]] [[cell surface receptor]]s and may treat constipation due to [[opioid analgesic]]s.<ref name="pmid1
    8 KB (1,081 words) - 09:21, 19 July 2010
  • 12 KB (1,658 words) - 08:52, 28 June 2011
  • Mast cells express a [[cell surface receptor]], ''c-kit''<ref name="pmid17555444">{{cite journal |author=Orfao A, Garcia
    13 KB (1,802 words) - 09:02, 1 March 2024
  • This table summarizes some of the actions of AVP at its three [[cell surface receptor]]s which are differently expressed in different tissues and exerting differ ...tan]], [[tolvaptan]], [[relcovaptan]], [[lixivaptan]]) act mainly on V1a [[cell surface receptor]]s.
    15 KB (1,951 words) - 10:35, 8 August 2011
  • ...to a polymorphism in African-American patients of the G protein–coupled [[cell surface receptor]] kinase (GRK5)([http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600870
    8 KB (1,068 words) - 08:39, 6 May 2024
  • To infect a cell, HBV first attaches to the cell surface receptor of the host cell. To insert the viral genome into the cell, the viral membr
    24 KB (3,686 words) - 21:08, 2 February 2012
  • ...PMID 16286160</ref> Other [[vasopressin]] antagonists act mainly on V1a [[cell surface receptor]]s.
    13 KB (1,669 words) - 07:45, 9 June 2014
  • G protein–coupled [[cell surface receptor]] kinase 2 (GRK2) [[genetic polymorphism]]s may also affect the response to
    35 KB (4,629 words) - 08:41, 6 May 2024
  • ...to a polymorphism in African-American patients of the G protein–coupled [[cell surface receptor]] kinase (GRK5) ([http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600870 ...PMID 16286160</ref> Other [[vasopressin]] antagonists act mainly on V1a [[cell surface receptor]]s.
    73 KB (10,150 words) - 21:46, 20 August 2014
  • There a several [[opioid receptor]]s. All are G-protein-coupled [[cell surface receptor]]s. Clinically useful analgesic families vary in their receptor effects; th
    42 KB (5,794 words) - 14:08, 2 February 2023
  • ...is a neuropeptide-modifier that acts on the N-Methyl-D-Aspartate (NMDA) [[cell surface receptor]]s for the [[neurotransmitter]] [[glutamate]].
    51 KB (6,994 words) - 18:19, 17 June 2024
View ( | next 20) (20 | 50 | 100 | 250 | 500)